These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 34681023)

  • 61. Single-cell transcriptome analysis reveals TOX as a promoting factor for T cell exhaustion and a predictor for anti-PD-1 responses in human cancer.
    Kim K; Park S; Park SY; Kim G; Park SM; Cho JW; Kim DH; Park YM; Koh YW; Kim HR; Ha SJ; Lee I
    Genome Med; 2020 Feb; 12(1):22. PubMed ID: 32111241
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Recent advancements in immunotherapy of melanoma using nanotechnology-based strategies.
    Bahreyni A; Mohamud Y; Luo H
    Biomed Pharmacother; 2023 Mar; 159():114243. PubMed ID: 36641926
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Single-Cell Transcriptomics of Liver Cancer: Hype or Insights?
    Zhang QY; Ho DW; Tsui YM; Ng IO
    Cell Mol Gastroenterol Hepatol; 2022; 14(3):513-525. PubMed ID: 35577269
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Immunotherapy in uveal melanoma: novel strategies and opportunities for personalized treatment.
    Masaoutis C; Kokkali S; Theocharis S
    Expert Opin Investig Drugs; 2021 May; 30(5):555-569. PubMed ID: 33650931
    [TBL] [Abstract][Full Text] [Related]  

  • 65. From bench to bedside: Single-cell analysis for cancer immunotherapy.
    Davis-Marcisak EF; Deshpande A; Stein-O'Brien GL; Ho WJ; Laheru D; Jaffee EM; Fertig EJ; Kagohara LT
    Cancer Cell; 2021 Aug; 39(8):1062-1080. PubMed ID: 34329587
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Immune Checkpoint Inhibitors: New Insights and Current Place in Cancer Therapy.
    La-Beck NM; Jean GW; Huynh C; Alzghari SK; Lowe DB
    Pharmacotherapy; 2015 Oct; 35(10):963-76. PubMed ID: 26497482
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Dissecting the tumor microenvironment in response to immune checkpoint inhibitors via single-cell and spatial transcriptomics.
    Liu W; Puri A; Fu D; Chen L; Wang C; Kellis M; Yang J
    Clin Exp Metastasis; 2023 Dec; ():. PubMed ID: 38064127
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Intratumoral Immunotherapy-Update 2019.
    Hamid O; Ismail R; Puzanov I
    Oncologist; 2020 Mar; 25(3):e423-e438. PubMed ID: 32162802
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Computational immunogenomic approaches to predict response to cancer immunotherapies.
    Addala V; Newell F; Pearson JV; Redwood A; Robinson BW; Creaney J; Waddell N
    Nat Rev Clin Oncol; 2024 Jan; 21(1):28-46. PubMed ID: 37907723
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Core immune cell infiltration signatures identify molecular subtypes and promote precise checkpoint immunotherapy in cutaneous melanoma.
    Zhu Z; Li G; Li Z; Wu Y; Yang Y; Wang M; Zhang H; Qu H; Song Z; He Y
    Front Immunol; 2022; 13():914612. PubMed ID: 36072600
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Single-cell analysis reveals new evolutionary complexity in uveal melanoma.
    Durante MA; Rodriguez DA; Kurtenbach S; Kuznetsov JN; Sanchez MI; Decatur CL; Snyder H; Feun LG; Livingstone AS; Harbour JW
    Nat Commun; 2020 Jan; 11(1):496. PubMed ID: 31980621
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Single-cell analysis of a tumor-derived exosome signature correlates with prognosis and immunotherapy response.
    Wu J; Zeng D; Zhi S; Ye Z; Qiu W; Huang N; Sun L; Wang C; Wu Z; Bin J; Liao Y; Shi M; Liao W
    J Transl Med; 2021 Sep; 19(1):381. PubMed ID: 34496872
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Myeloid Cell Classification and Therapeutic Opportunities Within the Glioblastoma Tumor Microenvironment in the Single Cell-Omics Era.
    Larkin CJ; Arrieta VA; Najem H; Li G; Zhang P; Miska J; Chen P; James CD; Sonabend AM; Heimberger AB
    Front Immunol; 2022; 13():907605. PubMed ID: 35784281
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Senescence-Related lncRNA Signature Predicts Prognosis, Response to Immunotherapy and Chemotherapy in Skin Cutaneous Melanoma.
    Lin K; Zhou Y; Lin Y; Feng Y; Chen Y; Cai L
    Biomolecules; 2023 Apr; 13(4):. PubMed ID: 37189408
    [TBL] [Abstract][Full Text] [Related]  

  • 75. De novo prediction of cell-type complexity in single-cell RNA-seq and tumor microenvironments.
    Woo J; Winterhoff BJ; Starr TK; Aliferis C; Wang J
    Life Sci Alliance; 2019 Aug; 2(4):. PubMed ID: 31266885
    [TBL] [Abstract][Full Text] [Related]  

  • 76. DNA methylation regulates TIGIT expression within the melanoma microenvironment, is prognostic for overall survival, and predicts progression-free survival in patients treated with anti-PD-1 immunotherapy.
    Niebel D; Fröhlich A; Zarbl R; Fietz S; de Vos L; Vogt TJ; Dietrich J; Sirokay J; Kuster P; Saavedra G; Ramírez Valladolid S; Hoffmann F; Strieth S; Landsberg J; Dietrich D
    Clin Epigenetics; 2022 Apr; 14(1):50. PubMed ID: 35410311
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Neoadjuvant Immunotherapy for Locally Advanced Melanoma.
    Pelster MS; Amaria RN
    Curr Treat Options Oncol; 2020 Feb; 21(2):10. PubMed ID: 32025932
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Identification of molecular subtyping system and four-gene prognostic signature with immune-related genes for uveal melanoma.
    Xia F; Yu Z; Deng A; Gao G
    Exp Biol Med (Maywood); 2022 Feb; 247(3):246-262. PubMed ID: 34743576
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Promising immunotherapeutic targets in lung cancer based on single-cell RNA sequencing.
    Xue Q; Peng W; Zhang S; Wei X; Ye L; Wang Z; Xiang X; Zhang P; Zhou Q
    Front Immunol; 2023; 14():1148061. PubMed ID: 37187731
    [TBL] [Abstract][Full Text] [Related]  

  • 80. 9-Gene Signature Correlated With CD8
    Yan K; Lu Y; Yan Z; Wang Y
    Front Immunol; 2021; 12():622563. PubMed ID: 34220795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.